Mycophenolic acid inhibits inosine 5′-monophosphate dehydrogenase and suppresses immunoglobulin and cytokine production of B cells

International Immunopharmacology

Volumn 3, Issue 1, 2003, Pages 31-37

  Jonsson, Charlotte A ^a   Carlsten, Hans ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

IFN ; IgG; IL 10; MPA

Indexed keywords

5' MONOPHOSPHATE DEHYDROGENASE; CYTOKINE; GUANOSINE; IMMUNOGLOBULIN; MYCOPHENOLIC ACID; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL ASSAY; CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG EXPOSURE; DRUG TARGETING; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME INHIBITION; HYBRIDOMA; IMMUNOMODULATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TIME;

ANIMALS; B-LYMPHOCYTES; CELL DIVISION; CELL SURVIVAL; HYBRIDOMAS; IMMUNOGLOBULIN G; IMP DEHYDROGENASE; INTERFERON TYPE II; INTERLEUKIN-10; MYCOPHENOLIC ACID;

EID: 0037238362     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00210-2     Document Type: Article

References (19)

1. Chan T.M., Li F.K., Tang C.S., Wong R.W., Fang G.X., Ji Y.L.et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N. Engl. J. Med. 343:2000;1156-1162.
2. Karim M.Y., Alba P., Cuadrado M.J., Abbs I.C., D'Cruz D.P., Khamashta M.A.et al. Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Rheumatology (Oxf.). 41:2002;876-882.
3. Jonsson C.A., Svensson L., Carlsten H. Beneficial effect of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice. Clin. Exp. Immunol. 116:1999;534-541.
4. Van Bruggen M.C., Walgreen B., Rijke T.P., Berden J.H. Attenuation of murine lupus nephritis by mycophenolate mofetil. J. Am. Soc. Nephrol. 9:1998;1407-1415.
5. Jonsson C.A., Erlandsson M., Svensson L., Mölne J., Carlsten H. Mycophenolate mofetil ameliorates perivascular T lymphocyte inflammation and reduces the double-negative T cell population in SLE-prone MRLlpr/lpr mice. Cell. Immunol. 197:1999;136-144.
6. Corna D., Morigi M., Facchinetti D., Bertani T., Zoja C., Remuzzi G. Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease. Kidney Int. 51:1997;1583-1589.
7. McMurray R.W., Elbourne K.B., Lagoo A., Lal S. Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB×NZW F1 mouse model of systemic lupus erythematosus. J. Rheumatol. 25:1998;2364-2370.
8. Jonsson C.A., Carlsten H. Inosine monophosphate dehydrogenase (IMPDH) inhibition in vitro suppresses lymphocyte proliferation and the production of immunoglobulins, autoantibodies and cytokines in splenocytes from MRLlpr/lpr mice. Clin. Exp. Immunol. 124:2001;486-491.
9. Sintchak M.D., Nimmesgern E. The structure of inosine 5′-monophosphate dehydrogenase and the design of novel inhibitors. Immunopharmacology. 47:2000;163-184.
10. Allison A.C., Eugui E.M. The design and development of an immunosuppressive drug, mycophenolate mofetil. Springer Semin. Immunopathol. 14:1993;353-380.
11. Allison A.C., Eugui E.M. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology. 47:2000;85-118.
12. Allison A.C., Hovi T., Watts R.W., Webster A.D. The role of de novo purine synthesis in lymphocyte transformation. Ciba Found. Symp. 1977;207-224.
13. Allison A.C., Hovi T., Watts R.W., Webster A.D. Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de-novo purine synthesis in lymphocyte transformation. Lancet. 2:1975;1179-1183.
14. Jonsson, CA, Carlsten, H. Mycophenolic acid inhibits inosine 5′-monophosphate dehydrogenase and suppresses production of pro-inflammatory cytokines, nitric oxide and LDH in macrophages. Cell Immunol, in press, accepted 2002-07-23.
15. Eugui E.M., Almquist S.J., Muller C.D., Allison A.C. Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Scand. J. Immunol. 33:1991;161-173.
16. Lanier L.L., Gutman G.A., Lewis D.E., Griswold S.T., Warner N.L. Monoclonal antibodies against rat immunoglobulin kappa chains. Hybridoma. 1:1982;125-131.
17. Czerkinsky C.C., Nilsson L.A., Nygren H., Ouchterlony O., Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods. 65:1983;109-121.
18. Yalowitz J.A., Jayaram H.N. Molecular targets of guanine nucleotides in differentiation, proliferation and apoptosis. Anticancer Res. 20:2000;2329-2338.
19. Rizzo M.T., Tricot G., Hoffman R., Jayaram H.N., Weber G., Garcia J.G.et al. Inosine monophosphate dehydrogenase inhibitors. Probes for investigations of the functions of guanine nucleotide binding proteins in intact cells. Cell. Signal. 2:1990;509-519.